Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$1.4B |
| 2 |
ExxonMobil
XOM
|
+$1.39B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$932M |
| 4 |
Procter & Gamble
PG
|
+$925M |
| 5 |
Walmart Inc
WMT
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$1.66B |
| 2 |
Salesforce
CRM
|
+$1.17B |
| 3 |
Lam Research
LRCX
|
+$974M |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$972M |
| 5 |
Applied Materials
AMAT
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.72% |
| 2 | Financials | 12.27% |
| 3 | Healthcare | 10.07% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
| $1.1M | ﹤0.01% |
38,937
-3,143
| -7% | -$88.7K |
|
677
Darling Ingredients
DAR
$9.44B
| $1.08M | ﹤0.01% |
23,294
-200
| -0.9% | -$8.8K |
|
678
AdvanSix
ASIX
$444M
| $1.06M | ﹤0.01% |
37,147
+81
| +0.2% | +$2.16K |
|
|
XYZ
679
Block Inc
XYZ
$47.5B
| $1.06M | ﹤0.01% |
12,525
-14,928
| -54% | -$1.08M |
|
680
Oppenheimer Holdings
OPY
$1.2B
| $1.06M | ﹤0.01% |
26,470
+3,125
| +13% | +$122K |
|
681
Accenture
ACN
$108B
| $1.05M | ﹤0.01% |
3,030
+72
| +2% | +$26.2K |
|
682
iShares MSCI USA Min Vol Factor ETF
USMV
$24.2B
| $1.05M | ﹤0.01% |
12,524
+8,285
| +195% | +$668K |
|
|
STR
683
DELISTED
Sitio Royalties
STR
| $1.03M | ﹤0.01% |
41,550
-683
| -2% | -$15.4K |
|
684
WisdomTree
WT
$3.22B
| $1.03M | ﹤0.01% |
111,632
| – | – |
|
685
AvalonBay Communities
AVB
$26.8B
| $1.02M | ﹤0.01% |
+5,500
| New | +$989K |
|
686
Shore Bancshares
SHBI
$796M
| $993K | ﹤0.01% |
86,338
| – | – |
|
687
iShares Russell 2000 ETF
IWM
$83B
| $992K | ﹤0.01% |
4,717
-902
| -16% | -$180K |
|
688
Vanguard Total International Bond ETF
BNDX
$82.2B
| $982K | ﹤0.01% |
19,966
-1,343
| -6% | -$65.6K |
|
|
DCPH
689
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $981K | ﹤0.01% |
62,372
| – | – |
|
690
Anika Therapeutics
ANIK
$287M
| $981K | ﹤0.01% |
38,620
| – | – |
|
691
Phillips 66
PSX
$81.4B
| $980K | ﹤0.01% |
5,998
-1,014
| -14% | -$146K |
|
692
Vanguard Morningstar Value ETF
VTV
$191B
| $964K | ﹤0.01% |
5,919
-1,763
| -23% | -$272K |
|
693
Gilead Sciences
GILD
$165B
| $959K | ﹤0.01% |
13,094
+788
| +6% | +$60.6K |
|
694
Americold
COLD
$4.27B
| $957K | ﹤0.01% |
+38,411
| New | +$1.05M |
|
|
CHUY
695
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $926K | ﹤0.01% |
27,460
| – | – |
|
696
Ironwood Pharmaceuticals
IRWD
$711M
| $914K | ﹤0.01% |
104,947
+1,816
| +2% | +$22K |
|
697
iShares Core S&P Mid-Cap ETF
IJH
$127B
| $904K | ﹤0.01% |
14,880
-3,700
| -20% | -$209K |
|
698
Wabtec
WAB
$49.3B
| $895K | ﹤0.01% |
6,142
-112
| -2% | -$15.2K |
|
699
Philip Morris
PM
$295B
| $882K | ﹤0.01% |
9,631
+1,058
| +12% | +$97.6K |
|
700
Movado Group
MOV
$841M
| $882K | ﹤0.01% |
31,582
| – | – |
|
Similar funds
Ken Fisher's Q1 2024 Portfolio in Review
As of Q1 2024, Ken Fisher held 1,068 positions worth $214B, up 13% from $189B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2024 filing shows 87 new, 392 increased, 448 reduced and 104 closed positions. Its largest new stake was Nomura Holdings: 8,478,338 shares worth $54.4M. The largest sale was ASML, an estimated $1.66B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q1 2024 buy was Nomura Holdings: 8,478,338 shares worth $54.4M.
- Ken Fisher added most to Chevron in Q1 2024, an estimated $1.4B increase.
- Ken Fisher's biggest Q1 2024 reduction was ASML, cutting an estimated $1.66B.
- Ken Fisher fully exited Veradigm Inc. Common Stock in Q1 2024, selling an estimated $23.8M.
- Ken Fisher's ten largest holdings make up 31% of its $214B portfolio in Q1 2024.
- Ken Fisher opened 87 new positions and closed 104 in Q1 2024.
- Ken Fisher's portfolio value rose 13% quarter-over-quarter to $214B.
Based on Fisher Asset Management's 13F filing for Q1 2024, filed 9 May 2024.